http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007128114-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6fabf5a8b7594f5ad81327047333144a |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0004 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-055 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0008 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-10 |
| filingDate | 2007-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6984b22739ed6270fdafa190fbee7435 |
| publicationDate | 2007-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2007128114-A1 |
| titleOfInvention | Method for monitoring protein translation |
| abstract | Disclosed is a method for monitoring early treatment response of a cancer treatment comprising measuring by magnetic resonance spectroscopy (MRS), for example, proton MRS, the amount of Choline present in the tissue adjoining or surrounding the cancerous tissue before and after treatment; the treatment comprises administration of an angiogenesis inhibitor, for example, a VEGF inhibitor, whereby a decrease in the amount of Choline after treatment is indicative of a positive response. The decrease in the amount of Choline represents the decrease in the internal cell membrane as a result of down regulation of the organelles and their secretory granules and their transport vesicles. Disclosed also is a method for determining effectiveness of an angiogenesis inhibitor in the treatment of cancer. Also disclosed are methods of monitoring early treatment response in diseases where an angiogenesis effector, i.e., an inhibitor or promoter of angiogenesis, is employed. Also disclosed is a method for monitoring protein translation related to angiogenesis. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014218023-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8131337-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8197795-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006177378-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7622102-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006177377-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006222591-A1 |
| priorityDate | 2005-02-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 464.